Cargando…
Treatment of dyslipidemia in patients with type 2 diabetes
Type 2 diabetes is associated with significant cardiovascular morbidity and mortality. Although low-density lipoprotein cholesterol levels may be normal in patients with type 2 diabetes, insulin resistance drives a number of changes in lipid metabolism and lipoprotein composition that render low-den...
Autor principal: | Vijayaraghavan, Krishnaswami |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022752/ https://www.ncbi.nlm.nih.gov/pubmed/21172030 http://dx.doi.org/10.1186/1476-511X-9-144 |
Ejemplares similares
-
Management of Dyslipidemia in Type 2 Diabetes: Recent Advances in Nonstatin Treatment
por: Sugiyama, Kazutoshi, et al.
Publicado: (2018) -
Therapies for the Treatment of Cardiovascular Disease Associated with Type 2 Diabetes and Dyslipidemia
por: Aguilar-Ballester, María, et al.
Publicado: (2021) -
Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment
por: Halpern, Alfredo, et al.
Publicado: (2010) -
Diabetes Dyslipidemia
por: Schofield, Jonathan D., et al.
Publicado: (2016) -
Revisiting cardiovascular risk reduction in type 2 diabetes and dyslipidemia
por: Lim, Phillip, et al.
Publicado: (2022)